{
"vaccines" : [{"id" : 0 ,
  "name" : "Inactivated Influenza (IIV)",
  "indication" : "Recommended for all adults" ,
  "administration":"One <b>IIV</b> dose every year in the fall or winter",
  "contrain":"- Previous severe allergic reaction <br> - Moderate or severe acute illness with or without fever"
},

  {"id" : 1 ,
    "name" : "Tetanus, diphtheria, pertussis(Td:Tdap)",
    "indication" : "All people who lack written documentation of a primary series consisting of at least 3 doses of tetanus- and diphtheria-toxoid-containing vaccine" ,
    "administration":"Substitute 1-time dose of Tdap for Td booster; then boost with Td every 10 yrs",
    "contrain":"- Previous severe allergic reaction<br> - For Tdap only, history of encephalopathy not attributable to an identifiable cause, within 7d following DTP/DTaP, or Tdap"
  },


  {"id" : 2 ,
    "name" : "Pneumococcal conjugate (PCV13)",
    "indication" : "For all adults with chronic liver diseases if some other risk factor is present: Age ≥65 years, Cerebrospinal fluid leak, Cochlear implant, Functional or anatomic asplenia, hemoglobinopathies, HIV infection, Chronic renal failure  and Nephrotic syndrome, Leukemia, Lymphoma, generalized malignancy, immunosuppression" ,
    "administration":"<b>Schedule for dual vaccination</b> - A single dose of PCV13 followed by a dose of PPSV23 ≥8 weeks later should be given for adults with liver disease who are ≥65 years or have any of the risk factors (mentioned before) and who have not previously received either PCV13 or PPSV23.<br> For patients who have previously received one or more doses of PPSV23, a  single dose of PCV13 should be given ≥1 year after the last PPSV23 dose was received.<br>Revaccination with single dose of PPSV23 >5 year in immunocompromised and at 65 years old.",
    "contrain":"- Previous severe allergic reaction to this vaccine, including (for PCV13) to any diphtheria toxoid-containing vaccine, or to any of its components<br> - Moderate or severe acute illness"
  },


  {"id" : 3 ,
    "name" : "Pneumococcal polysaccharide(PPSV23)",
    "indication" : "All chronic liver diseases patients because they have an increased risk of death from pneumococcal bacteremia & pulmonary complications" ,
    "administration":"- 2 doses for adults aged 19 through 64 years, 5yrs apart <br> For age 65yrs they need a 2nd dose, at least 5 years since previous dose if 1st dose was given prior to age 65",
    "contrain":"- Previous severe allergic reaction to this vaccine, including (for PCV13) to any diphtheria toxoid-containing vaccine, or to any of its components<br> - Moderate or severe acute illness"
  },


  {"id" : 4 ,
    "name" : "Hepatitis A (HepA) IM",
    "indication" : "Adults who want to be protected from (HAV) infection For chronic liver diseases patients & for persons who receive clotting factor concentrates" ,
    "administration":"2-dose series with a minimum of 6 month interval",
    "contrain":"- Previous severe allergic reaction <br> - Moderate or severe acute illness"
  },


  {"id" : 5 ,
    "name" : "Hepatitis B (HepB) IM",
    "indication" : "All persons with chronic liver disease including, HCV infection, cirrhosis, fatty liver disease" ,
    "administration":"3-dose series at 0, 1 and 6 month intervals",
    "contrain":"- Previous severe allergic reaction <br> - Moderate or severe acute illness"
  },


  {"id" : 6 ,
    "name" : "MMR (Measles, Mumps, Rubella)",
    "indication" : "Individuals at higher risk of either exposure or morbidity e.g., Healthcare personnel, college students, Military personnel, international travelers, Household and close contacts of immunocompromised persons, HIV-infected individuals who do not have current evidence of severe immunosuppression" ,
    "administration":"- Adults with no evidence of immunity should get 1 dose of MMR unless the adult is in a high risk group<br> - Individuals at high risk should have two doses separated by at least one month or serologic evidence of immunity",
    "contrain":"- Previous severe allergic reaction<br> - Pregnancy or possibility of pregnancy within 4wks<br> - Immuno-compromising conditions<br> - Severe immunodeficiency<br> - History of thrombocytopenia or thrombocytopenic purpura"
  },

  {"id" : 7 ,
    "name" : "Zoster (Shingles)",
    "indication" : "Recommended for adults aged 60 years or older regardless of whether they report a prior episode of herpes zoster" ,
    "administration":"1 dose",
    "contrain":"- Previous severe allergic reaction<br> - Primary cellular or acquired immunodeficiency<br> - Pregnancy<br> - Receipt of specific antivirals 24hrs before vaccination (i.e., acyclovir, famciclovir, or valacyclovir) 24hrs before vaccination, if possible; delay resumption of these antiviral drugs for 14d after vaccination<br> - Moderate or severe acute illness"
  },

  {"id" : 8 ,
    "name" : "Varicella (Chickenpox)",
    "indication" : "All adults without evidence of immunity to varicella<small><sup>*</small></sup>" ,
    "administration":"- 2 doses <br> - Dose #2 is given 4—8wks after dose #1. <br> - If dose #2 is delayed, do not repeat dose #1. Just give dose #2.",
    "contrain":"- Previous severe allergic reaction (e.g. anaphylaxis) Pregnancy<br> - Long-term immunosuppressive therapy or immunocompromised pts<br> - Receipt of specific antivirals<br> - Moderate or severe acute illness"
  },

  {"id" : 9 ,
    "name" : "Humanpapilloma virus (HPV)",
    "indication" : "-For unvaccinated females through age 26yrs: Complete a 3-dose series of HPV2 or HPV4<br> For unvaccinated males through age 21yrs: Complete a 3-dose series of HPV4",
    "administration":"- 3 doses on a 0, 1–2, 6m schedule. Use either HPV2 or HPV4 for women, and only HPV4 for men <br> - Must be at least 4wks between doses #1 and #2 and at least 12wks between doses #2 and #3 ",
    "contrain":"- Previous severe allergic reaction <br> - Moderate or severe acute illness <br> -Pregnancy"}]
,"icon" : "sec9logo"
,"name" : "Chronic Liver Diseases"
,"ref" : "*Evidence of immunity to varicella in adults includes any of the following:<br>- Documentation of 2 doses of varicella vaccine at least 4 weeks apart;<br>- History of varicella based on diagnosis or verification of varicella disease by a health care provider;<br>- History of herpes zoster based on diagnosis or verification of herpes zoster disease by a health care provider; <br>- Laboratory evidence of immunity or laboratory confirmation of disease.<br>1- Centers for Disease Control and Prevention. Department of Health and Human Services<br>2- Summary of Recommendations for Adult Immunization (Age 19 years and older). Centers for Disease Control and Prevention. 2015"
,"bg" : "sec9bg"
,"btnBg" : "sec9btnbg"
,"textColor" : "sec9color"
}
